https://multiplesclerosisnewstoday.com/news-posts/2023/06/19/potential-blood-biomarker-gilenya-response-found-ms-patients/
A microRNA called miR-548a-3p may help to identify MS patients who will attain no evidence of disease activity after treatment with Gilenya.
Create an account or login to join the discussion